ArticleEuropean journal of neurology2022

Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow-up.

Mattia Parisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.